Nikola Vidović
Milenko Dželetović
Olga Zorić

University of Defense, Military Academy – Belgrade, Republic of Serbia

University of Belgrade, Faculty of Security – Belgrade, Republic of Serbia

Academy “Dositej” – Belgrade, Republic of Serbia

2nd International Scientific Conference on Recent Advances in Information Technology, Tourism, Economics, Management and Agriculture – ITEMA 2018 – Graz, Austria, November 8, 2018, CONFERENCE PROCEEDINGS published by the Association of Economists and Managers of the Balkans, Belgrade, Serbia; ISBN 978-86-80194-13-4


The pharmaceutical industry is an economic branch that is primarily concerned with the production of pharmaceutical preparations, medicines and other products, and at the same time it is one of the strategic branches of the economy of each state. Observing the problem, through systematic analysis, the focus in the paper was put on the time interval in the last ten years when the privatization procedures were intensively implemented over the largest Serbian pharmaceutical companies. Through the econometric indicators, the influence and consequences on the current state of the pharmaceutical industry in the Republic of Serbia have been also highlighted.

In the course of the research, through financial analysis, the most successful companies from the pharmaceutical sector of the economy of the Republic of Serbia are pointed out through the financial indicators the liquidity and the performance of the business were analyzed. Also, by economic and financial approach, the share that the former holders of the pharmaceutical industry had in production in relation to the current situation, where the processing sector prevails, will be highlighted.

Key words

pharmaceutical industry, Republic of Serbia, analysis, finance, economy

[1] Kesič, D. (2009). Strategic analysis of the world pharmaceutical industry, Management, Vol. 14, 1, pp. 59-76.
[2] Pharma Strategy Group London, Current Issues, 2003, 2004, 2005, 2006, Pharma Strategy Group Ltd., London
[3] Lazarevic, I. (2011). Financial Flows in the Pharmaceutical Market, Part I, magazine BB – Informator, pp. 46-52.
[4] Jovovic, M., Maksimovic, D., Marcetic, M. (2015). The effects of privatization in Serbia. BizInfo Journal, Vol. 6, No. 2, pp. 31-49.
[5] Lazarević, I. (2011). Liquidity of the pharmaceutical market, Part II, magazine BB – Informator, pp. 53-60.
[6] Hašimbegović, T. (2013). An analysis of the global pharmaceutical industry with a special focus on the market for pharmaceutical products in Serbia, Singidunum University, pp. 2-7.
[7] Statistical office of Republic of Serbia (2017). Statistical yearbook for 2017, pp. 303-349.
[8] Ministry of economy, Agency for privatization, Purchase contract for Galenika a.d. Belgrade, Retrieved from on 24th October, 2018.
[9] Ministry of economy, Agency for privatization, Purchase contract for Zorka pharm a.d. Šabac, retrieved from on 24th October, 2018.
[10] Ministry of economy, Agency for privatization, Purchase contract for Zdravlje a.d. Leskovac, retrieved from on 24th October, 2018
[11] Chamber of commerce and industry of Serbia, Pharmaceutical and medical economics data, retrieved from on 3rd November, 2018.
[12] Bošković, G. (2011). Necessity of export oriented strategy of re-industrialization of Serbia, Economic issues XLIX, No. 2, pp. 235-249.


Association of Economists and Managers of the Balkans – UdEkoM Balkan
179 Ustanicka St, 11000 Belgrade, Republic of Serbia

ITEMA conference publications are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.